GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 28, 2024 |
PDB ID | UniProt ID ▲ | Title | Descriptor |
---|---|---|---|
7TFN | Q2N0S6 | Cryo-EM structure of CD4bs antibody Ab1303 in complex with HIV-1 Env trimer BG505 SOSIP.664 | |
7TXD | Q2N0S6 | Cryo-EM structure of BG505 SOSIP HIV-1 Env trimer in complex with CD4 receptor (D1D2) and broadly neutralizing darpin bnD.9 | |
7UCF | Q2N0S6 | Structure of the BG505 SOSIP.664 trimer in complex with neutralizing antibody Fab fragments 10-1074 and BG24 | |
8FIS | Q2N0S6 | Structure of Bispecific CAP256V2LS-J3 Fab in complex with BG505 DS-SOSIP.664 | |
8TTW | Q2N0S6 | Cryo-EM structure of BG505 SOSIP.664 HIV-1 Env trimer in complex with temsavir, 8ANC195, and 10-1074 | |
7MDT | Q2N0S6 | BG505 SOSIP.v5.2 in complex with the monoclonal antibody Rh4O9.8 (as Fab fragment) | |
7MDU | Q2N0S6 | BG505 SOSIP MD39 in complex with the monoclonal antibodies Rh.33104 mAb.1 and RM20A3 | |
7TFO | Q2N0S6 | Cryo-EM structure of HIV-1 Env trimer BG505 SOSIP.664 in complex with CD4bs antibody Ab1573 | |
8DP1 | Q2N0S6 | Cryo-EM structure of HIV-1 Env(BG505.T332N SOSIP) in complex with DH1030.1 Fab | |
8VFV | Q2N0S6 | HIV Env BG505_MD39_B16 SOSIP boosting trimer in complex with B16_d77.5 mouse Fab and RM20A3 Fab | |
8TOX | Q2N0S6 | Cryo-EM structure of BG505 Env mutant A517E in complex with antibody ACS202 Fab | |
8FYJ | Q2N0S6 | Structure of HIV-1 BG505 SOSIP-HT2 in complex with two CD4 molecules (class I) | |
6X97 | Q2N0S6 | Cryo-EM model of HIV-1 Env BG505 SOSIP.664 in complex with rabbit monoclonal antibody 11A fragment antigen binding variable domain | |
6X98 | Q2N0S6 | Cryo-EM model of HIV-1 Env BG505 SOSIP.664 in complex with rabbit monoclonal antibody 11B fragment antigen binding variable domain | |
8FR6 | Q2N0S6 | Antibody vFP53.02 in complex with HIV-1 envelope trimer BG505 DS-SOSIP | |
8G85 | Q2N0S6 | vFP52.02 Fab in complex with BG505 DS-SOSIP Env trimer | |
8G9W | Q2N0S6 | Cryo-EM structure of vFP49.02 Fab in complex with HIV-1 Env BG505 DS-SOSIP.664 (conformation 1) | |
8G9X | Q2N0S6 | Cryo-EM structure of vFP49.02 Fab in complex with HIV-1 Env BG505 DS-SOSIP.664 (conformation 2) | |
8G9Y | Q2N0S6 | Cryo-EM structure of vFP49.02 Fab in complex with HIV-1 Env BG505 DS-SOSIP.664 (conformation 3) | |
8GAS | Q2N0S6 | vFP48.02 Fab in complex with BG505 DS-SOSIP Env trimer | |
8G4M | Q2N0S6 | Vaccine-elicited human antibody 2C06 in complex with HIV-1 envelope trimer BG505 DS-SOSIP | |
8G4T | Q2N0S6 | Vaccine-elicited human antibody 2C09 in complex with HIV-1 envelope trimer BG505 DS-SOSIP | |
7SQ1 | Q2N0S6 | BG505.MD39TS Env trimer in complex with Fab from antibody C05 | |
7UOJ | Q2N0S6 | The CryoEM structure of N49-P9.6-FR3 and PGT121 Fabs in complex with BG505 SOSIP.664 | |
7T9B | Q2N0S6 | ApexGT5 in complex with GT5-d42.16 and RM20A3 Fabs | |
8FK5 | Q2N0S6 | Cryo-EM Structure of PG9RSH DU011 Fab in complex with BG505 DS-SOSIP.664 | |
8FL1 | Q2N0S6 | Cryo-EM Structure of PG9RSH DU025 Fab in complex with BG505 DS-SOSIP.664 | |
8FLW | Q2N0S6 | Cryo-EM Structure of PGT145 DU303 Fab in complex with BG505 DS-SOSIP.664 | |
8E1P | Q2N0S6 | Crystal structure of BG505 SOSIP.v4.1-GT1.2 trimer in complex with gl-PGV20 and PGT124 Fabs | |
8TJR | Q2N0S6 | CRYO-EM STRUCTURE OF HIV-1 BG505DS-SOSIP.664 ENV TRIMER BOUND TO HERH-c.01 FAB | |
8TJS | Q2N0S6 | CRYO-EM STRUCTURE OF HIV-1 BG505DS-SOSIP.664 ENV TRIMER BOUND TO GPZ6-a.01 FAB | |
8TOP | Q2N0S6 | Cryo-EM structure of HIV-1 Env BG505 DS-SOSIP in complex with antibody GPZ6-b.01 targeting the fusion peptide | |
8TQ1 | Q2N0S6 | HIV-1 BG505 Env SOSIP in complex with bovine Fab Bess4 and non-human primate Fab RM20A3 | |
8SW4 | Q2N0S6 | BG505 GT1.1 SOSIP in complex with NHP Fabs 21N13, 21M20 and RM20A3 | |
6CDE | Q2N0S7 | Cryo-EM structure at 3.8 A resolution of vaccine-elicited antibody vFP20.01 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 | PGT122 Heavy chain, PGT122 Light Chain, VRC03 Light Chain, VRC03 Heavy Chain, Glycoprotein 41, Glycoprotein 120, vFP20.01 Heavy Chain, vFP20.01 Heavy chain |
6MPG | Q2N0S7 | Cryo-EM structure at 3.2 A resolution of HIV-1 fusion peptide-directed antibody, A12V163-b.01, elicited by vaccination of Rhesus macaques, in complex with stabilized HIV-1 Env BG505 DS-SOSIP, which was also bound to antibodies VRC03 and PGT122 | A12V163-b.01 Light Chain, Envelope glycoprotein gp41, Envelope glycoprotein gp120, A12V163-b.01 Heavy Chain, PGT122 Heavy chain, PGT122 Light chain, VRC03 heavy chain, VRC03 Light chain |
7N65 | Q2N0S7 | Complex structure of HIV superinfection Fab QA013.2 and BG505.SOSIP.664 | |
6CUF | Q2N0S7 | Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody vFP1.01 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 | PGT122 Heavy chain, PGT122 Light Chain, VRC03 Light Chain, VRC03 Heavy Chain, Glycoprotein 41, Glycoprotein 120, vFP20.01 Heavy Chain, vFP20.01 Heavy chain |
7LL2 | Q2N0S7 | Cryo-EM structure of BG505 DS-SOSIP in complex with Glycan276-Dependent Broadly Neutralizing Antibody VRC33.01 Fab | |
7LL1 | Q2N0S7 | Cryo-EM structure of BG505 DS-SOSIP in complex with glycan276-dependent broadly neutralizing antibody VRC40.01 Fab | |
6MN7 | Q2N0S7 | Cryo-EM structure of BG505.SOSIP.664 in complex with BF520.1 antigen binding fragment | Envelope Glycoprotein gp120, Envelope Glycoprotein gp41, BF520.1 Fab variable region |
6MPH | Q2N0S7 | Cryo-EM structure at 3.8 A resolution of HIV-1 fusion peptide-directed antibody, DF1W-a.01, elicited by vaccination of Rhesus macaques, in complex with stabilized HIV-1 Env BG505 DS-SOSIP, which was also bound to antibodies VRC03 and PGT122 | DF1W-a.01 heavy chain, DF1W-a.01 Light chain, Envelope glycoprotein gp120, Envelope glycoprotein gp41, PGT122 heavy chain, PGT122 Light Chain, VRC03 Heavy chain, VRC03 Light Chain |
6CDI | Q2N0S7 | Cryo-EM structure at 3.6 A resolution of vaccine-elicited antibody vFP16.02 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 | VRC03 Heavy Chain, VRC03 light chain, PGT122 Heavy Chain, PGT122 Light Chain, Glycoprotein 120, Glycoprotein gp41, vFP16.02 Heavy Chain, vFP16.02 Light Chain |
6CH7 | Q2N0S7 | XFEL crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex with the broadly-neutralizing antibodies BG18 and 35O22 | Envelope glycoprotein gp160, 35O22 Heavy Chain, 35O22 Light Chain, BG18 Heavy Chain, BG18 Light Chain |
6CH8 | Q2N0S7 | Crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex with the broadly-neutralizing antibodies BG18 and 35O22 | |
6CM3 | Q2N0S7 | BG505 SOSIP in complex with sCD4, 17b, 8ANC195 | Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab light chain, 17b Fab heavy chain, 8ANC195 Fab heavy chain, 8ANC195 Fab light chain |
6CRQ | Q2N0S7 | Glutaraldehyde-treated BG505 SOSIP.664 Env in complex with PGV04 Fab | |
6DID | Q2N0S7 | HIV Env BG505 SOSIP with polyclonal Fabs from immunized rabbit #3417 post-boost#1 | Envelope glycoprotein gp160, Monoclonal antibody 10A light chain, Monoclonal antibody 10A heavy chain |
6CUE | Q2N0S7 | Cryo-EM structure at 4.0 A resolution of vaccine-elicited antibody vFP7.04 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 | PGT122 Heavy chain, PGT122 Light Chain, VRC03 Light Chain, VRC03 Heavy Chain, Glycoprotein 41, Glycoprotein 120, vFP20.01 Heavy Chain, vFP20.01 Heavy chain |
6N1W | Q2N0S7 | Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody DFPH-a.15 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 | Envelope glycoprotein gp120, DFPH-a.15 heavy chain, DFPH-a.15 Light chain, Envelope glycoprotein gp41, PGT122 Light chain, PGT122 Heavy chain, VRC03 Light chain, VRC03 Heavy chain |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024